NDC 71332-002-01
TAVALISSE 150 mg/1
FOSTAMATINIB · TABLET
TAVALISSE is a tablet containing fostamatinib at a strength of 150 mg/1. Manufactured by Rigel Pharmaceuticals, Inc..
Key Facts
- Brand Name
- TAVALISSE
- Generic Name
- FOSTAMATINIB
- NDC Code (Package)
71332-002-01- NDC Code (Product)
71332-002- Manufacturer
- Rigel Pharmaceuticals, Inc.
- Strength
- 150 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA209299
- Marketing Start
- 05/09/2018
Recall History
No Recall HistoryView Full Drug Page
TAVALISSE — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.